SCHEMBL17023160

SCHEMBL17023160

CCN1CCN(c2ccc(NC(=O)Oc3ccc(-c4c(Cl)c(OC)cc(OC)c4Cl)c4nccnc34)cn2)CC1

nearest known ligand 0.80

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 19/20 0.80
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
MCHR1 Q99705 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023031 0.90 FGFR3 (0.65) FGFR3
SCHEMBL17023062 0.89 FGFR3 (0.66) FGFR3MAPT
SCHEMBL1126244 0.89 FGFR3 (1.00) FGFR3
SCHEMBL17023115 0.89 FGFR3 (0.67) FGFR3
SCHEMBL17023101 0.89 FGFR3 (0.64) FGFR3
SCHEMBL17023067 0.87 FGFR3 (0.65) FGFR3TP53
SCHEMBL17023176 0.85 FGFR3 (0.80) FGFR3
SCHEMBL17023138 0.82 FGFR3 (0.67) FGFR3
SCHEMBL17023167 0.82 FGFR3 (0.69) FGFR3
SCHEMBL17023181 0.81 FGFR3 (0.59) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed